Company Overview and News

60
7 Great Vanguard Funds to Buy

2018-09-14 investorplace
Vanguard funds, be they index funds or exchange-traded funds, are wildly popular with financial advisers and investors. One of the primary reasons Vanguard funds have such receptive audiences is their low fees.
FB VEA VTV NFLX BND GOOG VBK VXF VB AMZN T BNDX BNDW GOOGL AAPL VZ DIS

2
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

2018-08-31 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the First Trust Small Cap Growth AlphaDEX Fund (FYC - Free Report) , a passively managed exchange traded fund launched on 04/19/2011.
FYC IWO SCVL MEDP AMED VBK BEAT PAYC

 
A Spread of Top-Ranked Growth ETFs Hitting All-Time Highs

2018-08-28 zacks
After a lackluster July, growth stocks seem to have regained their appeal this month. This is especially true given that the S&P 500 Growth Index is up 3.9% so far this month, outpacing the gain of 1.6% for the S&P 500 Value Index. Strong rebound in large-capitalization technology and Internet stocks as well as surging earnings led to investors’ appetite for more risk. Double-digit earnings growth in the second quarter is expected to be the highest quarterly growth pace in almost eight years.
JKE REGN IWO SCHG IWF VONG SLYG VBK

 
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

2018-08-07 zacks
Designed to provide broad exposure to the Small Cap Growth segment of the US equity market, the First Trust Small Cap Growth AlphaDEX Fund (FYC - Free Report) is a passively managed exchange traded fund launched on 04/19/2011.
FYC IWO AMT WWE VBK YEXT BEAT GTLS

 
5 ETFs to Buy as Q2 GDP Growth Hits 4-Year High of 4.1%

2018-07-30 investorplace
American economy has been on a solid growth path. This is especially true as U.S. GDP growth expanded 4.1% annually in the second quarter, representing the fastest pace of growth in nearly four years. The number is almost double the revised Q1 growth rate of 2.2%. With this, GDP expanded 3.1% for the first half of the year.
IUSG VBK

 
5 ETFs to Buy as Q2 GDP Growth Hits 4-Year High of 4.1%

2018-07-30 zacks
American economy has been on a solid growth path. This is especially true as U.S. GDP growth expanded 4.1% annually in the second quarter, representing the fastest pace of growth in nearly four years. The number is almost double the revised Q1 growth rate of 2.2%. With this, GDP expanded 3.1% for the first half of the year. The growth was driven by strong consumer spending, surge in exports business, increase in business investments, and higher government spending.
VBK ITA

 
5 Safe and Sound ETF Strategies for 2H

2018-07-12 investorplace
After a bumpy ride in the first half of the year, global stocks are bouncing back, with iShares MSCI ACWI Index Fund (NASDAQ:ACWI), which targets the global stock market, up 1% last week. The U.S. stocks, as indicated by SPDR S&P 500 ETF (NYSEARCA:SPY), which tracks the S&P 500 index, is up 1.5% to start the second half versus 0.6% gain for Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU), which targets the international equity market excluding the United States.
ACWI ALFA FBT VTV PSCT AIRR IJT VBK FV FTLB

44
7 Best Vanguard Funds for the Second Half of 2018 | InvestorPlace

2018-07-11 investorplace - 1
The S&P 500 gained 2.5% in the first half of the year, delivering a decent though not jaw-dropping performance. With the second half of the year, now could be an ideal time for some investors to consider reconfiguring their portfolios or buy some of the first half’s outperforming (or laggard) funds.
FB AMZN T GOOGL VIGI AAPL VZ NFLX NYTAB GOOG VBK VWO

 
5 Safe and Sound ETF Strategies for 2H

2018-07-09 zacks
After a bumpy ride in the first half of the year, global stocks are bouncing back, with iShares MSCI ACWI ETF (ACWI - Free Report) , which targets the global stock market, up 1% last week. The U.S. stocks, as indicated by SPDR S&P 500 ETF (SPY - Free Report) , which tracks the S&P 500 index, is up 1.5% to start the second half versus 0.6% gain for Vanguard FTSE All-World ex-US ETF VEU, which targets the international equity market excluding the United States.
ACWI IWO ALFA FBT VTV IVE VEU XSW IBLN VBK FV

 
6 Small-Cap ETFs That Have Surged to #1 This Summer

2018-06-25 investorplace
The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month.
IJT VBK

4
6 Small-Cap ETFs That Have Surged to #1 Rank in Summer

2018-06-25 zacks
The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month. Small-cap stocks seem to be the hottest investment cluster for this summer. This is especially true in the wake of escalating trade tensions between the United States and some of its key partners, and bouts of upbeat data showing encouraging domestic economic fundamentals.
IWO KHC VIOG SLYG VBK

1
How to Build a Winning ETF Portfolio Amid Trade War Fears

2018-06-22 zacks
The global stock market has been on a bumpy ride given fears of a global trade war that has kept investors’ on the edge. This is especially true in the wake of escalating tariff talks between the United States and its major allies, especially China. However, economic fundamentals remained sound given the raft of upbeat data, which shows that the economy is piping hot with unemployment dropping to 3.
FNDX IWO BBH SCHV SLYG IGM VBK SPYV

24
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

2018-06-18 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the First Trust Small Cap Growth AlphaDEX Fund (FYC - Free Report) , a passively managed exchange traded fund launched on 04/19/2011.
FYC TWLO IWO WWE VBK AAXN

 
5 Small-Cap ETFs With Big-Time Upside Potential

2018-05-27 investorplace
Small-cap stocks and the corresponding exchange traded funds (ETFs) are on a tear. Over the past week, the widely followed Russell 2000 index is up nearly 3%, bringing its year-to-date gain to over 7%. By comparison, the large-cap S&P 500 is up just over 3% this year.
VBK

49
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?

2018-05-22 zacks
Looking for broad exposure to the Small Cap Growth segment of the US equity market? You should consider the Vanguard S&P Small-Cap 600 Growth ETF (VIOG - Free Report) , a passively managed exchange traded fund launched on 09/09/2010.
IWO ASGN VIOG CHE FIVE VBK AKAM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 922908595